Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00860951 · ClinicalTrials.gov registry record · Phase 1

P300 Brain Computer Interface Keyboard to Operate Assistive Technology

A Phase 1 study, sponsored by University of Michigan.

Completed
Registry status
Phase 1
Development phase
29
Enrollment target

NCT00860951: Completed Phase 1 study, sponsored by University of Michigan.

NCT00860951 is a Phase 1 study that has completed, run by University of Michigan. The registered enrollment target is 29 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (52% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00860951, a Phase 1 study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
Phase 1
Development phase
29 participants
Enrollment target

Study Summary

The purpose of this research is to develop tools enable people who are paralyzed to operate technology and access computers. These tools are called brain computer interfaces (BCIs). BCIs would let a person use brain signals to operate technology.

Primary Outcome

Accuracy for the sentence typed in each environment was calculated as the percentage of characters for which the result character matched the target character. The target characters were determined based on the next character needed to complete the sentence to be copied. In the case of errors, the next character was therefore a backspace to correct the error. The target characters were modified by subject comments to account for errors in selecting the next character. Once sentence was typed in

Interventions

  • DEVICE Brain Computer Interface Keyboard

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2008-09
Est. Completion 2012-05
Phase Phase 1
University of Michigan

1,327 total trials

What the finished NCT00860951 record still lists

NCT00860951 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (52% lower).

The record links to 0 conditions, and to 1 intervention - of which Brain Computer Interface Keyboard is the first listed.

NCT00860951 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00860951 about?

NCT00860951 is a clinical study titled "P300 Brain Computer Interface Keyboard to Operate Assistive Technology". The purpose of this research is to develop tools enable people who are paralyzed to operate technology and access computers. These tools are called brain computer interfaces (BCIs). BCIs would let a person use brain signals to operate technology.

What is the current status of trial NCT00860951?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 29 participants. The study started on 2008-09. Estimated completion is 2012-05.

What interventions are being tested in trial NCT00860951?

The interventions under investigation include: Brain Computer Interface Keyboard (DEVICE).

Who is sponsoring clinical trial NCT00860951?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00860951's enrollment target sits among peer trials

29 1440th of 2000 higher than 554 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02429557 · 29 participants · Phase 1

    Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

  • NCT02568878 · 29 participants · Phase 3

    Creatine for Depressed Male and Female Methamphetamine Users

  • NCT03014401 · 29 participants · NA

    The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

  • NCT03128996 · 29 participants · Phase 1

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00860951, the US trial registry maintained by the National Library of Medicine. NCT00860951 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.